These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25113149)

  • 41. The nuclear medicine physician should be responsible for the hybridic PET/CT equipment and the radiologist act as an advisor.
    Chatzipanagiotou T; Mastorakou A
    Hell J Nucl Med; 2007; 10(3):181. PubMed ID: 18273956
    [No Abstract]   [Full Text] [Related]  

  • 42. Status and Development of Nuclear Medicine Over One Decade in Beijing.
    Luo F; Geng J; Chen S
    World J Nucl Med; 2024 Jun; 23(2):73-78. PubMed ID: 38933075
    [No Abstract]   [Full Text] [Related]  

  • 43. PET/CT a hybridic equipment based on PET studies.
    Zissimopoulos A
    Hell J Nucl Med; 2007; 10(3):182. PubMed ID: 18273957
    [No Abstract]   [Full Text] [Related]  

  • 44. Increase in utilization of myocardial perfusion imaging in the Czech Republic: activity and practice of nuclear cardiology, 2003.
    Kamínek M; Myslivecek M; Lang O; Fikrle A
    Nucl Med Rev Cent East Eur; 2005; 8(1):11-4. PubMed ID: 15977141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity and practice of nuclear cardiology in the Czech Republic, 2001.
    Kamínek M; Husák V; Myslivecek M; Lang O
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):321-4. PubMed ID: 12552354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current status of nuclear medicine in Japan].
    Endo K
    Gan To Kagaku Ryoho; 1999 May; 26(6):744-8. PubMed ID: 10410141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Will high-resolution/high-sensitivity SPECT ensure that PET is not the only survivor in nuclear medicine during the next decade?
    Seret A
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):533-5. PubMed ID: 19148641
    [No Abstract]   [Full Text] [Related]  

  • 48. [Nuclear Medicine in Germany. Key data from official statistics].
    Hellwig D; Grgic A; Kotzerke J; Kirsch CM
    Nuklearmedizin; 2011; 50(2):53-67. PubMed ID: 21479336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Theranostics: The Role of Quantitative Nuclear Medicine Imaging.
    Könik A; O'Donoghue JA; Wahl RL; Graham MM; Van den Abbeele AD
    Semin Radiat Oncol; 2021 Jan; 31(1):28-36. PubMed ID: 33246633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. UK nuclear medicine survey 2003-2004.
    Hart D; Wall BF
    Nucl Med Commun; 2005 Nov; 26(11):937-46. PubMed ID: 16208170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current trends in pediatric nuclear medicine: a Society for Pediatric Radiology membership survey.
    Sammer MBK; Sher AC; States LJ; Trout AT; Seghers VJ
    Pediatr Radiol; 2020 Jul; 50(8):1139-1147. PubMed ID: 32399687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment of National Diagnostic Reference Levels for Administered Activity in Diagnostic Nuclear Medicine in Thailand.
    Suttho D
    J Nucl Med Technol; 2024 Jun; 52(2):158-162. PubMed ID: 38627011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new era for Nuclear Medicine neuroimaging in Spain: Where do we start from in Spain?
    Balsa MA; Camacho V; Garrastachu P; García-Solís D; Gómez-Río M; Rubí S; Setoain X; Arbizu J;
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):219-226. PubMed ID: 28237122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Nuclear medicine and radiopharmaceuticals].
    Sopena Novales P; Plancha Mansanet MC; Martinez Carsi C; Sopena Monforte R
    Radiologia; 2014 Jun; 56 Suppl 1():29-37. PubMed ID: 25304301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.
    Pacilio M; Lauri C; Prosperi D; Petitti A; Signore A
    Semin Nucl Med; 2018 May; 48(3):261-276. PubMed ID: 29626943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Global Trends Survey for Targeted Radionuclide Therapy].
    Hanaoka K; Maeda T; Miyaji N; Sakaguchi K; Yoneyama H; Ogawa M; Tsushima H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018 Dec; 74(12):1443-1448. PubMed ID: 30568095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. South Thames Nuclear Medicine Survey 1996-97. South Thames Regional Nuclear Medicine Specialty Service Committee.
    Wells CP; Burwood RJ; Forbes EK
    Nucl Med Commun; 1997 Nov; 18(11):1098-108. PubMed ID: 9423211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarkers in Randomized Clinical Trials: Positron Emission Tomography and Nuclear Medicine Techniques.
    Singhal T; Stern E
    Front Neurol Neurosci; 2016; 39():109-16. PubMed ID: 27463807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neurological explorations in Nuclear Medicine. A Spanish survey].
    Serena A; Mora J; Serrano J; González F; Pavía J; Soriano A;
    Rev Esp Med Nucl; 2003; 22(3):133-8. PubMed ID: 12747825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. European research trends in nuclear medicine.
    Inubushi M; Tatsumi M; Yamamoto Y; Kato K; Tsujikawa T; Nishii R
    Ann Nucl Med; 2018 Nov; 32(9):579-582. PubMed ID: 30242670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.